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Our understanding of the relationship between the neuroanatomic loci of brain damage and the incidence
of post-stroke depression (PSD) is not complete. Many studies have investigated this relationship and
the evidence is conflicting. With the purpose of gaining a consistent, strong, and credible conclusion on
the relationship between PSD and the loci of brain damage, a meta-analysis was used in this study to
systematically reanalyze the findings of related studies and to investigate the sources of heterogeneity
among study results. The key words “stroke or cerebrovascular” and “depression or mood or affective”
were entered into the MEDLINE, PsycINFO, and EMBASE databases to search for relevant studies. The
references cited in the studies found were also used to locate additional studies. For each eligible study,
the important study characteristics were recorded, and the effect sizes of the relationship between PSD
and lesion location were computed. Furthermore, we conducted subgroup analyses to explore the
heterogeneity among study results. A total of 3,668 patients participating in 52 studies were included in
this meta-analysis. There was a weak relationship between PSD and right hemisphere lesion. The major
sources of heterogeneous study results included systematic exclusion of patients with language dysfunction
and use of different assessors and instruments for diagnosing depression. Future efforts should aim to
enhance standards for reporting studies, improve assessment tools for assessing depression of aphasic
patients, and adopt appropriate study methodologies for investigating the relationship between PSD and
lesion location.
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The hypothesis that depression after stroke is associated
with brain lesion location has been the focus of research and
debates among scholars and clinical specialists for many
years [1–8]. This hypothesis was widely publicized and at-
tractive because it links neurobiology with clinical practice
[1,2]. However, the evidence is conflicting. Many of the stud-
ies conducted by Robinson and his research team, scholastic
viewpoints, and textbooks support the association be-
tween depression and left-hemisphere lesions [1,2,9–12]. In
contrast, some studies suggest the opposite result, that de-
pression is associated with right-hemisphere lesions [13–
16]. Other studies do not confirm any association between
depression after stroke and brain lesion location [17–20].
In view of the apparently conflicting evidence, questions
about whether certain anatomic correlates can predict sub-
sequent depression should be clarified. This information
would help clinicians to identify, at an earlier stage, patients
at highest risk for depression, and identify those stroke vic-
tims most likely to benefit from treatment interventions,
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and perhaps contribute to better understanding of the etio-
logy and biology of depression. If successful treatment can
be instituted, rehabilitation may be shortened, costs reduced,
quality of life improved, and unnecessary premature deaths
prevented [16].
The two previous systematic reviews of this topic did
not substantiate any definitive statement about the re-
lationship between location of stroke lesion and risk of
depression, but there were some drawbacks in the review
techniques. One review was not a meta-analysis [5], while
the other used meta-analysis but included only studies
with a categorical diagnosis of depression [6].
Meta-analysis, a quantitative method of summarizing
existing studies, is defined as an analysis of analyses. That
is, the pooled results of individual studies that have pre-
viously appeared to be contradictory or confusing are re-
analyzed to provide a systematic, quantitative review of the
data, thus permitting strong, credible conclusions.
The purposes of this study were to employ meta-
analytical techniques to update the previous meta-analysis
results and to more completely address the relationship
between post-stroke depression (PSD) and lesion location,
and to further explore the heterogeneity that might exist
among study results.
MATERIALS AND METHODS
Literature search
Several approaches were adopted to identify relevant
studies. First, a search of the following databases, up to
April 2003, was conducted: MEDLINE (from January 1966),
PsycINFO (from January 1987), and EMBASE (from 1988).
The key words used to identify articles included “stroke or
cerebrovascular” and “depression or mood or affective”.
The search was restricted to studies published in English
and involving human subjects. At this stage, abstracts of
approximately 4,552 studies were identified and reviewed.
Second, the relevant journals, such as Stroke, Journal of
Neurology, American Journal of Psychiatry, and Journal of
Neurology, Neurosurgery and Psychiatry, were hand searched
for the period between May and July 2003. Third, all articles
cited in the systematic review by Carson et al were surveyed
and selected if they met our inclusion criteria [6]. Finally,
the references cited in the articles identified by the above
approaches were used to locate additional studies.
Up to this stage, approximately 233 potentially eligible
studies were obtained.
Several inclusion criteria were adopted in this meta-
analysis. First, the studies must have examined the asso-
ciation between depression after stroke and lesion loca-
tion. Second, they must have provided information suffi-
cient for the computation of effect sizes. Third, dupli-
cate studies were excluded. These were defined as studies
that shared a sampling frame, and had overlapping study
dates, overlapping grant funding numbers, and similar
or identical reported sample characteristics. Among dupli-
cate studies, the study conducted with the largest number
of participants was selected. If the studies were conducted
on the same number of participants, the earliest one was
chosen. Case studies, review articles, and pharmacologi-
cal intervention studies were excluded. In total, 52 studies
were included in our meta-analysis [1,10,13–62].
Characteristic variables coded from each study
A coding sheet was designed to record relevant data from
each study: exclusion of patients with language dysfunc-
tion, assessor for diagnosing depression, instrument for
diagnosing depression, time between stroke and diagnosis
of depression, lesion location, source of patients, and study
quality.
According to the methodological suggestions outlined
by Singh et al [5], as well as our judgments based on a litera-
ture review of PSD, the criteria for evaluating the quality
of a study in this meta-analysis included the following
items: adequacy of study methodology (e.g. blind to neuro-
imaging assessment, valid depression diagnosis), clarity
of description of subjects’ characteristics (e.g. age, edu-
cational level), clarity of screening criteria for study sub-
jects (e.g. excluding patients with previous psychiatric his-
tory, excluding patients with multiple strokes), and scope
of the study (e.g. study that also assessed subjects’ cog-
nitive functions, social support functions). A total of 23
items, with score 1 or 0, was thus obtained to grade the
quality of each study. Studies with scores of between 1 and
8 were considered low-quality studies, those with scores
of 9 to 16 were medium-quality studies, and studies with
scores of 17 to 23 were high-quality studies.
Inter-rater agreement
To ensure the reliability of the literature search process,
during the first stage, approximately 10% of the 4,552 online
abstracts found were randomly selected and independent-
ly read by two authors (YHW and SHY) to judge their eligi-
bility for inclusion in the meta-analysis on the basis of the
same criteria. The inter-rater agreement was 98%. In the
final stage, the same reliability check was repeated for the
233 potentially eligible studies. The inter-rater agreement
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was 96%. Furthermore, to ensure the reliability of the coding
of the study characteristics, 26 studies were randomly
drawn from the final set of 52 studies and independently
coded by the same authors. Of seven study characteristics,
inter-coder agreement was 92% for judging the exclusion of
patients with language dysfunction, 85% for rating study
quality, and 100% for the remaining study characteristics.
Disagreements in coding were eventually resolved through
discussion.
Computation and analysis of effect sizes
Each study result was represented in the form of effect
sizes. The effect size calculated in this meta-analysis was
referred to as d, indicating the difference of the means of
depression scores between patients with left-hemisphere
lesions and those with right-hemisphere lesions, and then
divided by the pooled standard deviation, when depression
scores were of continuous nature in a study. When a study
reported only the frequencies or proportions of diagnosed
depression, the difference in the proportion (or frequency
transformed into proportion) between depressed patients
with left-side lesions and those with right-side lesions was
calculated instead. Effect size was positive if depression
was more severe for patients with left-side lesions, and was
negative if depression was more severe for patients with
right-side lesions. The effect sizes from all studies were
combined to obtain the overall effect size by averaging the
d values, with each d weighted by the reciprocal of its vari-
ance [63]. The overall effect size, which was a weighted
mean effect size denoting the degree of association between
PSD and lesion location as a whole, was then tested for its
statistical significance. A statistical test of homogeneity for
all d values (indicated by QW) was performed to determine
whether all the reviewed studies shared a common effect
size [63].
To explore the heterogeneity among study results, we
conducted analyses in which subgroups were formed
according to each study characteristic. The weighted mean
effect sizes, d+, in subgroups of each study characteristic
were computed and tested for significance using 95% con-
fidence intervals (95% CI). If the 95% CI of any subgroup
did not include zero, the weighted mean effect size of that
subgroup was statistically significant. Again, test of homo-
geneity of the effect sizes (QW) within each subgroup was
performed. If QW was significant, it implied that studies
within the same subgroup did not derive from a homogen-
eous population. Finally, the d+ values were converted to
the weighted mean correlations (r+ values).
Some studies in our review yielded multiple outcome
measures (i.e. multiple data points). These multiple outcome
measures were obtained from different assessors, different
assessment scales, different assessment time points, or
different lesion locations within a hemisphere. As such, a
single study may have yielded more than one effect size.
Following common practice, we averaged effect sizes over
multiple outcome measures within a study when computing
the overall effect size. However, these multiple outcome
measures were still applicable to the subsequent subgroup
analyses. In total, 52 studies yielded 75 effect sizes. The total
number of subjects included in this meta-analysis was 3,668
(1,775 subjects with left-side lesions and 1,893 subjects with
right-side lesions). In this review, the computation of effect
sizes was based on means and standard deviations for 48%
of the studies, and proportions or frequencies for 48% of the
studies; only 4.0% of effect sizes were obtained and converted
from F, t, or p values. The DSTAT computer program [64],
which was developed based on Hedges and Olkin’s statistical
techniques [63], was used for all data analyses.
RESULTS
Among all the effect sizes computed, the largest and smallest
effect sizes were 1.54 and –0.98, respectively. Thirty studies
yielded negative effect sizes and only 10 of these effect sizes
reached the 0.05 level of significance; 22 studies yielded
positive effect sizes and only four of these effect sizes
reached significance. Across the 52 aggregated studies, the
overall weighted mean effect size, –0.0801 (p = 0.0145, 95%
CI = –0.146/–0.014), was significantly different from zero at
the 0.05 significance level, indicating an association between
PSD and right-hemisphere lesions, but this association
was weak. Furthermore, the distribution of effect sizes was
heterogeneous, Q(51) = 120.298 (p < 0.001). After six outlier
studies were excluded, homogeneity among effect sizes
was obtained and yielded a weighted mean effect size,
 –0.0876 (p = 0.011, 95% CI = –0.16/–0.02), that was similar
to the value obtained when all studies were included. The
Table summarizes the results of subsequent subgroup
analyses.
Most of the studies reviewed excluded patients with
language dysfunction and adopted standardized rating
scales for diagnosing depression (Table). Among the as-
sessors for depression, there were more doctors, clinicians,
and clients themselves than other assessors. Among the
times for diagnosing depression after stroke, most studies
assessed depression within the first 9 months after stroke.
About half of studies were conducted with inpatient sub-
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jects. Most studies were judged to have medium quality,
and a few studies investigated the relationship between de-
pression and different locations of brain lesion in inter- or
intra-hemispheric comparisons.
Table. Summary of statistics in each subgroup according to study characteristics
k d+ 95% CI r+ QW
Exclusion of patients with language dysfunction
Yes 32 –0.1270 –0.2078/–0.0462 –0.0634 65.8073*
No 7 0.3414 0.0933/ 0.5896 0.1683 25.1621*
Assessors for diagnosing depression
Doctor 19 –0.0523 –0.1656/ 0.0609 –0.0262 46.1167*
Clinician 13 –0.0575 –0.2056/ 0.0906 –0.0288 24.8055†
Nurse 4 –0.2130 –0.4145/–0.0114 –0.1059 2.8407
Client self-report 12 –0.1337 –0.2987/ 0.0313 –0.0667 38.2025*
Family members 3 –0.1219 –0.4029/ 0.1592 –0.0608 5.6035
Mixed assessors 4 –0.1737 –0.3187/–0.0286 –0.0865 2.0903
Instruments for diagnosing depression
Clinical diagnostic criteria 15 –0.0440 –0.1609/ 0.0728 –0.0220 42.1669*
Structured interviews 1 0.2020 –0.6767/ 1.0808 0.1005 0.0000
Standardized scales 32 –0.1329 –0.2178/–0.0480 –0.0663 67.4285*
Observer rating scales 2 –0.1902 –0.6731/ 0.2927 –0.0947 1.6344
Research diagnostic criteria 2 0.3945 –0.1353/ 0.9243 0.1935 0.0151
Mixed measures 3 –0.2550 –0.4935/–0.0164 –0.1265 1.3821
Time (mo) of diagnosing depression after stroke
≤ 1 13 0.1256 –0.0448/ 0.2960 0.0627 33.3436*
2–3 15 –0.1301 –0.2647/ 0.0046 –0.0649 38.7566*
4–9 16 –0.1272 –0.2235/–0.0309 –0.0635 25.4426
10–15 5 –0.0296 –0.2698/ 0.2107 –0.0148 0.6398
16–21 2 –0.3205 –0.6842/ 0.0431 –0.1582 0.4994
22–27 1 0.1967 –0.2393/ 0.6327 0.0979 0.0000
28–39 1 –0.0157 –0.5231/ 0.4918 –0.0078 0.0000
≥ 40 1 0.5055 –0.1096/ 1.1207 0.2451 0.0000
Sources of patients
Inpatients 27 –0.0301 –0.1201/ 0.0599 –0.0151 86.0062*
Rehabilitation units 17 –0.1271 –0.2401/–0.0141 –0.0634 14.8532
Community 6 –0.1102 –0.3205/ 0.1000 –0.0550 10.3406
Lesion location of stroke§
Left anterior vs right anterior lesions 7 0.0156 –0.1831/ 0.2143 0.0078 21.8388‡
Left intermediate vs right intermediate lesions 3 –0.1831 –0.4873/ 0.1211 –0.0911 0.4004
Left posterior vs right posterior lesions 6 –0.1805 –0.4340/ 0.0731 –0.0899 1.9775
All anterior vs all posterior lesions 6 –0.0056 –0.1795/ 0.1682 –0.0028 5.9095
Left anterior vs all other lesions 6 –0.0698 –0.2512/ 0.1115 –0.0349 9.7403
Left anterior vs left posterior lesions 6 0.0172 –0.2704/ 0.2361 –0.0086 12.7147
Right anterior vs right posterior lesions 6 –0.0244 –0.2729/ 0.2241 –0.0122 9.1650
Study quality
High 4 0.0494 –0.2292/ 0.3281 0.0247 1.2958
Medium 45 –0.0802 –0.1498/–0.0106 –0.0401 111.7039*
Low 3 –0.2555 –0.5822/ 0.0712 –0.1267 1.6905
*p < 0.001; †p < 0.05; ‡p < 0.01; §effect sizes for each study in the subgroups were derived from the comparison between the first item and
the second item. k = number of studies/effect sizes in the subgroup; d+ = weighted mean effect size; 95% CI = 95% confidence interval;
r+ = weighted mean correlation; QW = test of homogeneity of effect sizes.
Kaohsiung J Med Sci August 2004 • Vol 20 • No 8
L. Yu, C.K. Liu, J.W. Chen, et al
376
As shown in the Table, the weighted mean effect sizes
within both subgroups for exclusion of patients with
language dysfunction were significantly different from zero.
This indicated that studies conducted with exclusion of
language-impaired patients supported the relationship
between PSD and right-hemisphere lesions, whereas
studies conducted without exclusion of such patients
showed the reverse trend, i.e. that depression was associat-
ed with left-hemisphere lesions. The follow-up compari-
son showed that the difference between both subgroups
was significant. There was evidence of significant hetero-
geneity among the studies within each subgroup. This im-
plied that studies within each subgroup of this study cha-
racteristic were not homogeneous. Studies using nurses as
assessors and standardized scales as assessment instru-
ments indicated a relationship between depression and
right-hemisphere lesions (Table). This was also true of
studies employing mixed assessors and mixed measures.
However, no association was found between depression
and lesion location when different brain regions were con-
sidered. Studies in which depression was assessed with-
in the first 4 to 9 months of stroke showed that depression
was associated with right-side lesions. Studies of medium
quality also showed the same trend, as did studies of pa-
tients in rehabilitation units. Further, there was evidence of
significant heterogeneity in the subgroups with more
studies, indicating that the study results had more variabi-
lity in these subgroups.
DISCUSSION
This study investigated the relationship between PSD and
lesion location by conducting a meta-analysis of studies
from the last 20 years [1]. While an earlier review by Carson
et al did not support the claim that PSD was associated with
lesion location [6], the results of our meta-analysis revealed
that there was a significant, although weak, relationship
between PSD and right-hemisphere lesions. Our finding
might result from the factors of systematic sample exclusion
as well as from the assessors and assessment tools for
diagnosing depression. We found that many of the studies
we reviewed employed standardized scales for assessing
depressive disorders. This phenomenon, accompanied by
systematic exclusion of patients with language dysfunction,
might lead the overall effect size obtained in this meta-
analysis to reach statistical significance, indicating that PSD
was associated with right-hemisphere lesions.
Carson et al employed the methods of DerSimonian and
Laird to compute effect sizes indexed as relative risks [6]. In
contrast, we used methods developed by Hedges and Ol-
kin to compute effect sizes indexed as standardized mean
differences, d. Our meta-analysis was conducted 4 years
after Carson et al’s study, and we aggregated studies that
included both continuous and categorical data of depres-
sion. Carson et al analyzed 35 studies that included only
categorical depression data. Although in their meta-analysis,
the 95% CI for the overall estimate of the relative risk in-
cluded 1 when all studies were included, the overall esti-
mate of the relative risk, 0.93, seemed to indicate that more
patients with right-side lesions were depressed.
As for language impairments, our finding supported
those of earlier studies that reported a relationship between
aphasia and depression [9,28]. In most of the studies we
reviewed, patients with left-hemisphere damage had been
excluded from samples because of the language comprehen-
sion or expression difficulties caused by stroke. It is con-
ceivable that many of the excluded patients with left-
hemisphere damage were also depressed. Consequently, the
existence and severity of depression in patients with left-
hemisphere damage may be underestimated, which in
turn yielded the result that depression was associated with
right-hemisphere lesions. In contrast, from studies that did
not exclude patients with language dysfunction, we found
a moderate association between PSD and left-hemisphere
lesions. Most investigators of PSD have attempted to exclude
patients with aphasia because patients with substantially
impaired comprehension have difficulties completing most
standardized interviews and scales [65]. Such a systematic,
selective exclusion of patients with language dysfunction,
which was commonly found in the studies we reviewed,
would have introduced sampling bias into research designs of
PSD studies and affected the reliability of PSD assessment [4].
As for the characteristics of the assessors and types of
instruments, this study cross-analyzed the depression
characteristics and language characteristics and found that
a majority of studies adopting standardized depression
scales excluded patients with language impairments. This
sampling method may be the reason for the statistically
significant relationship between depression after stroke
and right-side lesions found in the studies using stan-
dardized depression scales, nurse assessors, and mixed
assessors. As for the categories of doctors and clinicians, the
finding showed no correlation, which could be influenced
by different evaluation dimensions and breadth, such as
clinical interviews, observations, and judgments. In this
review, we found that there was a significant relationship
between types of assessment instruments and assessors.
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Most doctors used clinical diagnostic criteria (e.g. the Diag-
nostic and Statistical Manual of Mental Disorders and In-
ternational Classification of Diseases systems), while most
of the clinicians, nurses, and patients used standardized
scales (e.g. Hamilton Rating Scale for Depression, Beck
Depression Inventory, Zung Self-Rating Depression Scale,
Center for Epidemiologic Studies Depression Scale, Min-
nesota Multiphasic Personality Inventory). The issues con-
cerning the potential effect of using different assessment
tools and different assessors in the evaluation of PSD were
not investigated by Carson et al [6].
In Carson et al’s study, no evidence supported the
hypothesis that the time between stroke and diagnosis of
depression was an important confounder. Lesion location
was not associated with depression no matter when the de-
pressive symptoms after stroke were assessed. However,
our meta-analysis showed that depression was statistically
associated with right-hemisphere lesions when depression
was assessed within 4 to 9 months after stroke. When de-
pression was assessed within the first month after stroke,
the weighted mean effect size was positive, which implied
that depression was associated with left-side lesions, but
the association was not statistically significant. This finding
contradicts the general findings obtained by Robinson and
associates [1,2].
In the meta-analysis conducted by Carson et al, there
was evidence showing a risk of depression with right-side
lesions among patients selected from the community, but
not among patients in hospital or in rehabilitation units.
However, our meta-analysis showed that depression was
associated with right-side lesions among patients in reha-
bilitation units but not among patients in hospital or in the
community.
Consistent with Carson et al, our meta-analysis found
no relationship between PSD and lesions in any locations of
the hemispheres (anterior, intermediate, and posterior). In
other words, in both Carson et al’s and our meta-analyses,
the severity of depression did not differ in terms of different
brain regions assessed. However, in both Carson et al’s and
our meta-analyses, the sample size only included seven
studies or less.
As for the evaluation of study quality, we found that
most studies were of medium quality, and that there was an
association between PSD and lesion location in these
studies. Similar to the findings of Carson et al, we found no
relationship between PSD and lesion location among high-
quality studies.
Generally speaking, although this study supported the
relationship between PSD and right-side lesions, the
relationship was weak and may not have much practical
significance. Also, it should be kept in mind that whenever
the sample size in a subgroup is small, the result of that
subgroup should be interpreted with caution.
In summary, our findings showed that PSD was slightly
associated with right-side lesions, while Carson et al showed
no association. These findings contradict the common beliefs
generally held by doctors and clinicians in medical settings.
Further research is needed to validate these findings.
While reviewing the literature, we found that, while
brain lesion location and stroke severity can be diagnosed
by instruments, depression assessment cannot be complete
without the use of language. Through language, the patient’s
inner feelings and thought processes can be understood
and further utilized as a criterion for diagnosing depression
severity and type. Taking into consideration that different
stroke damage features directly or indirectly influence the
accuracy of depression diagnosis, some studies excluded
patients with severe aphasia or with comprehension dif-
ficulty. In contrast, studies that did not take this into consi-
deration did not exclude patients with aphasia. Most stud-
ies adopted traditional criteria or assessment instru-
ments for diagnosing depression after stroke. These tra-
ditional diagnostic criteria or instruments were originally
developed for use in non-brain-damaged patients and have
not been adapted to take into account the ways in which the
symptoms of brain damage may affect and alter the clinical
presentation of depression [4]. Patients with brain injury
could change, or even lose, some of their functions (e.g.
language, cognition, emotion, awareness, social function).
Due to the possible changes in self-awareness, language
expression, interpersonal interaction, emotion, personality,
or physical functioning, assessment results become biased
or cannot be applied. On the basis of our study results, we
suggest that multiple information sources, accurate neuro-
imaging techniques, or multidimensional neuropsycho-
logic assessment instruments be adopted to reduce the
influence of the change in some functions on assessment
accuracy. If methods designed to evaluate the depression
of non-brain-injured patients are to be used to reliably as-
sess those with brain damage, these methods should be
specifically validated for neurologically impaired popu-
lations [3,4].
Although the reviewed studies claimed that their topics
were the same or similar (investigation of the relationship
between depression after stroke and brain lesion location),
their operational definitions were different, such as criteria
for sampling, definitions of disease, ways of assessment,
types of assessment instruments, and assessment time.
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These discrepancies may lead to differences in the nature
and characteristics of studies. When the statistical test of
homogeneity is significant, the sources of heterogeneity
among study results should be investigated [66]. The
exploration of heterogeneity presents opportunities to in-
crease the relevance of the conclusions drawn and enhance
the understanding of the studies reviewed [67].
At the beginning of our meta-analysis, many possible
influential study characteristics were analyzed, such as
type of stroke, blinding of neuroimaging assessments, le-
sion volume, proximity of the lesion to the frontal pole,
past psychiatric history, family psychiatric history, and
history of stroke. However, because quite a few of the
reviewed studies did not provide clear or detailed des-
criptions of research methods and procedures, the ana-
lyses became difficult. Also, because some of these study
characteristics were examined in only a few studies
and were further subdivided, the sample size of each sub-
group became very small, and the generalizability of the
findings became limited. Due to these limitations, the
above study characteristics were not further analyzed.
There has been a consensus among meta-analysts that
enhancing the standards for primary study reporting
is necessary to provide sufficient information for sub-
sequent replication and reanalyses.
For future primary studies and meta-analyses, in
addition to the discreet investigation on the relationship
between PSD and brain lesion location, underlying
mechanisms interacting between lesion location and PSD,
as well as their influences, and how to effectively help
patients to become healthy should be investigated.
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